Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas

International Journal of Cancer

Volumn 88, Issue 1, 2000, Pages 28-36

  Yoshikawa, Kiyotsugu ^a   Ogawa, Tomoko ^b   Baer, Richard ^c   Hemmi, Hiromichi ^d   Honda, Kazuo ^e   Yamauchi, Akira ^a   Inamoto, Takashi ^a   Ko, Kohaku ^a   Yazumi, Shujiro ^a   Motoda, Hirotoshi ^a   Kodama, Hiroshi ^f   Noguchi, Shinzaburo ^g   Gazdar, Adi F ^h   Yamaoka, Yoshio ^a   Takahashi, Rei ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Kodama Breast Clinic   (Japan)

^g OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53;

ARTICLE; BREAST; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA REPAIR; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SOMATIC MUTATION;

ANIMALS; BRCA1 PROTEIN; BREAST; BREAST NEOPLASMS; CARRIER PROTEINS; DNA REPAIR; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENES, BRCA1; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS; RAD51 RECOMBINASE; RATS; RATS, NUDE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 0033856663     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4     Document Type: Article

References (47)

1. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A
2. Common nonsense mutations in RAD52
3. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
4. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner
5. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas
6. Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers
7. BRCA1 inhibition of estrogen receptor signaling in transfected cells
8. Eps15, a novel tyrosine kinase substrate, exhibits transforming activity
9. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: Pathological correlations
10. BRCA1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities
11. Partial rescue of BRCA1 (5-6) early embryonic lethality by p53 or p21 null mutation
12. In vitro repression of BRCA1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells
13. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
14. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains
15. Infrequent occurrence of microsatellite instability in sporadic and familial breast cancer
16. Mutations in the BRCA1 gene in Japanese breast cancer patients
17. High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
18. Nonsense mutation at codon 63 of the BRCA1 gene in Japanese breast cancer patients
19. Undectable expression of hMLH1 protein in sporadic colorectal cancer with replication error phenotype
20. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53
21. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
22. Clinidopathological analysis of BRCA1- or BRCA2-associated hereditary breast cancers in Japanese women
23. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH)
24. Association of BRCA1 with Rad51 in mitotic and meiotic cells
25. BRCA1 is a component of the RNA polymerase II holoenzyme
26. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
27. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
28. Homologous recombination and the roles of double-strand breaks
29. Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA
30. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death
31. Overexpression of p53, c-erbB-2 and epidermal growth factor receptor in human breast carcinomas
32. Localization of RecA-like recombination proteins on chromosomes of the lily at various meiotic stages
33. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
34. Characterization of a breast cancer cell line derived from germ-line BRCA1 mutation carrier
35. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice
36. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells
37. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer
38. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
39. Identification of a RING protein that can interact in vivo with the BRCA1 gene product
40. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
41. Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells
42. BRCA1 interacts with components of the histone deacetylase complex
43. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases
44. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtlP, a protein implicated in the CtBP pathway of transcriptional repression
45. BRCA1 physically associates with p53 and stimulates its transcriptional activity
46. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response